Concepedia

Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602

Yozo Sato, Hirokazu Watanabe, Miyuki Sone, Hiroaki Onaya, Noriaki Sakamoto, Keigo Osuga, Masahide Takahashi, Yasuaki Arai

Upsala Journal of Medical Sciences · 2012 · 72 citations · 12 references

DOIFull text

Open access

Abstract

Considerable differences in the CR rate and the response rate were observed. From the viewpoint of the high inter- and intra-observer reproducibility, mRECIST may be more suitable for tumor response criteria in clinical trials of TACE for HCC.

References

12

The Measurement of Observer Agreement for Categorical Data

J. Richard Landis, Gary G. Koch · Biometrics · 1977 · 76.3K citations · Full text

, , +20

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 28.6K citations

, , +9

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +17

Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

Jordi Bruix, Morris Sherman, Josep M. Llovet et al. · Journal of Hepatology · 2001 · 4.1K citations

, , +10

Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics

Marı́a Varela, María Isabel Real, Marta Burrel et al. · Journal of Hepatology · 2006 · 918 citations

, , +9